Answers are grounded in this paper and cite their sources.
Evaluates toxicological effects of Vernonia amygdalina in rodents, indicating no significant harm at tested doses.
Background: Vernonia amygdalina, commonly known as bitter leaves, is a staple vegetable in the culinary traditions of many equatorial African societies. Traditionally, these leaves have been used to manage psychiatric disorders, malaria, and diabetes, and are also recognised for boosting the immune system and providing antioxidant benefits. Objectives: This study aimed to evaluate the acute and sub-acute toxicological effects of the ethyl acetate fraction derived from Vernonia amygdalina, using male and female mice for the acute study and female rats for the sub-acute study. Methods: The toxicological assessments were conducted in accordance with the protocols established by the Organisation for Economic Cooperation and Development (OECD guidelines 423 and 407). In the acute phase of the study, a solitary dose of 2000 mg/kg of Vernonia amygdalina was administered via the oral route to both male and female mice. Observations included mortality rates, alterations in behaviour, and fluctuations in body weight. In the sub-acute phase, female rats were subjected to oral administration of Vernonia amygdalina at dosages of 100, 200, and 400 mg/kg over a duration of 28 days. Evaluative measures included mortality, behavioural alterations, changes in weight, as well as biochemical, haematological, and histopathological analyses. Results: The administration of Vernonia amygdalina did not elicit any observable alterations in behaviour or weight, and no mortality was recorded. Similarly, in the sub-acute toxicity evaluation, we noted an absence of behavioural changes, weight fluctuations, or mortality, alongside no statistically significant differences in all assessed parameters. Conclusion: The ethyl acetate fraction of V. amygdalina showed no significant adverse effects on behaviour, body weight, haematological, or biochemical indices in both acute and sub-acute studies, though mild histological changes were observed at higher doses (400 mg/kg). These findings suggest a wide safety margin but recommend caution at elevated doses.
No takes yet. Share an insight, caveat, or question.
Aitokhuehi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: